Letters
Somatic mutations and anti–mutated citrullinated vimentin antibodies in rheumatoid arthritis: Comment on the editorial by Levesque et al
First published: 28 December 2009
No abstract is available for this article.
- 1
Levesque MC,
Zhou Z,
Moreland LW.
Anti–cyclic citrullinated peptide testing for the diagnosis of rheumatoid arthritis and the quest for improved sensitivity and predictive value [editorial].
Arthritis Rheum
2009;
60:
2211–5.
- 2
Bang H,
Egerer K,
Gauliard A,
Luthke K,
Rudolph PE,
Fredenhagen G, et al.
Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis.
Arthritis Rheum
2007;
56:
2503–11.
- 3
Firestein GS,
Echeverri F,
Yeo M,
Zvaifler NJ,
Green DR.
Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium.
Proc Natl Acad Sci U S A
1997;
94:
10895–900.
- 4
Reme T,
Travaglio A,
Gueydon E,
Adla L,
Jorgensen C,
Sany J.
Mutations of the p53 tumour suppressor gene in erosive rheumatoid synovial tissue.
Clin Exp Immunol
1998;
111:
353–8.
- 5
Inazuka M,
Tahira T,
Horiuchi T,
Harashima S,
Sawabe T,
Kondo M, et al.
Analysis of p53 tumour suppressor gene somatic mutations in rheumatoid arthritis synovium.
Rheumatology (Oxford)
2000;
39:
262–6
- 6
Da Sylva TR,
Connor A,
Mburu Y,
Keystone E,
Wu GE.
Somatic mutations in the mitochondria of rheumatoid arthritis synoviocytes.
Arthritis Res Ther
2005;
7:
R844–51.
- 7
Cannons JL,
Karsh J,
Birnboim HC,
Goldstein R.
HPRT− mutant T cells in the peripheral blood and synovial tissue of patients with rheumatoid arthritis.
Arthritis Rheum
1998;
41:
1772–82.
- 8
Lee SH,
Chang DK,
Goel A,
Boland CR,
Bugbee W,
Boyle DL, et al.
Microsatellite instability and suppressed DNA repair enzyme expression in rheumatoid arthritis.
J Immunol
2003;
170:
2214–20.
- 9
Van der Linden MP,
van der Woude D,
Ioan-Facsinay A,
Levarht EW,
Stoeken-Rijsbergen G,
Huizinga TW, et al.
Value of anti–modified citrullinated vimentin and third-generation anti–cyclic citrullinated peptide compared with second-generation anti–cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
Arthritis Rheum
2009;
60:
2232–41.
